ASRS
DAWN

Arizona State Retirement System’s Day One Biopharmaceuticals DAWN Stock Holding History

Arizona State Retirement System’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$423K Sell
19,742
-569
-3% -$8.02K ﹤0.01% 1548
2025
Q4 		$189K Buy
20,311
+842
+4% +$7.03K ﹤0.01% 1933
2025
Q3 		$137K Buy
19,469
+258
+1% +$1.77K ﹤0.01% 2034
2025
Q2 		$125K Buy
19,211
+3,309
+21% +$22.8K ﹤0.01% 2005
2025
Q1 		$126K Sell
15,902
-1,471
-8% -$15.8K ﹤0.01% 1992
2024
Q4 		$220K Buy
17,373
+453
+3% +$6.3K ﹤0.01% 1914
2024
Q3 		$236K Buy
16,920
+3,466
+26% +$49.5K ﹤0.01% 1888
2024
Q2 		$185K Buy
13,454
+297
+2% +$4.34K ﹤0.01% 1921
2024
Q1 		$217K Sell
13,157
-216
-2% -$3.23K ﹤0.01% 1884
2023
Q4 		$195K Buy
13,373
+1,010
+8% +$12.2K ﹤0.01% 1963
2023
Q3 		$152K Buy
12,363
+995
+9% +$13K ﹤0.01% 1984
2023
Q2 		$136K Buy
+11,368
New +$148K ﹤0.01% 2051

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Arizona State Retirement System's DAWN Position: Q1 2026 in Review

Arizona State Retirement System reduced its Day One Biopharmaceuticals (DAWN) stake by 2.8% in Q1 2026, selling an estimated $8.02K and leaving 19,742 shares worth $423K. The position accounts for ﹤0.01% of the portfolio, ranked #1548.

Arizona State Retirement System first reported a position in DAWN in Q2 2023 and has held it in 12 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Arizona State Retirement System held 19,742 shares of Day One Biopharmaceuticals worth $423K as of Q1 2026.
  • Arizona State Retirement System sold 569 Day One Biopharmaceuticals shares in Q1 2026, an estimated $8.02K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Arizona State Retirement System's portfolio in Q1 2026, its #1548 holding.
  • Arizona State Retirement System first reported a position in Day One Biopharmaceuticals in Q2 2023 and has held it in 12 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.